Future of hepatitis C therapy: development of direct-acting antivirals.

Future of hepatitis C therapy: development of direct-acting antivirals.

Item
http://www.wikidata.org/entity/Q37928362
Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature.Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naïve infected individuals.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited SettingsNitric oxide in liver diseases.Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitorEstimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.Thiouracil cross-linking mass spectrometry: a cell-based method to identify host factors involved in viral amplification.HCV infection selectively impairs type I but not type III IFN signaling.Hepatitis C virus assembly imagingProtease inhibitors for hepatitis C: economic implications.Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands.Limited impact of awareness-raising campaigns on hepatitis C testing practices among general practitioners.
P2860

Future of hepatitis C therapy: development of direct-acting antivirals.

Item
http://www.wikidata.org/entity/Q37928362
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Future of hepatitis C therapy: development of direct-acting antivirals.
@en
Future of hepatitis C therapy: development of direct-acting antivirals.
@nl
type
label
Future of hepatitis C therapy: development of direct-acting antivirals.
@en
Future of hepatitis C therapy: development of direct-acting antivirals.
@nl
prefLabel
Future of hepatitis C therapy: development of direct-acting antivirals.
@en
Future of hepatitis C therapy: development of direct-acting antivirals.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Future of hepatitis C therapy: development of direct-acting antivirals.
@en
P2093
P304
P31
P356
10.1097/COH.0B013E32834B87F8
P433
P478
P50
P577
P698